New York State Common Retirement Fund’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$700K Buy
33,476
+8,900
+36% +$124K ﹤0.01% 1791
2025
Q4
$218K Buy
24,576
+9,000
+58% +$77.5K ﹤0.01% 2263
2025
Q3
$131K Buy
15,576
+9,000
+137% +$60.9K ﹤0.01% 2490
2025
Q2
$33.7K Hold
6,576
﹤0.01% 3041
2025
Q1
$9.01K Hold
6,576
﹤0.01% 3088
2024
Q4
$20.3K Hold
6,576
﹤0.01% 3032
2024
Q3
$50.6K Sell
6,576
-8,800
-57% -$84K ﹤0.01% 2863
2024
Q2
$132K Sell
15,376
-6,698
-30% -$51.8K ﹤0.01% 2604
2024
Q1
$175K Sell
22,074
-22
-0.1% -$236 ﹤0.01% 2511
2023
Q4
$219K Buy
22,096
+12,726
+136% +$110K ﹤0.01% 2423
2023
Q3
$106K Sell
9,370
-11,707
-56% -$71.4K ﹤0.01% 2692
2023
Q2
$70K Sell
21,077
-40
-0.2% -$144 ﹤0.01% 3050
2023
Q1
$83.4K Sell
21,117
-12,378
-37% -$71.8K ﹤0.01% 2862
2022
Q4
$243K Sell
33,495
-5
-0% -$35 ﹤0.01% 2645
2022
Q3
$121K Buy
33,500
+400
+1% +$1.71K ﹤0.01% 2959
2022
Q2
$150K Buy
+33,100
New +$200K ﹤0.01% 2919

Other funds holding TNGX

New York State Common Retirement Fund's TNGX Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Tango Therapeutics (TNGX) stake by 36% in Q1 2026, buying an estimated $124K and bringing the position to 33,476 shares worth $700K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

New York State Common Retirement Fund first reported a position in TNGX in Q2 2022 and has held it in 16 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • New York State Common Retirement Fund held 33,476 shares of Tango Therapeutics worth $700K as of Q1 2026.
  • New York State Common Retirement Fund bought 8,900 Tango Therapeutics shares in Q1 2026, an estimated $124K.
  • Tango Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #1791 holding.
  • New York State Common Retirement Fund first reported a position in Tango Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.